The purpose of the study is to evaluate the link between insulin resistance and alterations in skeletal muscle mitochondrial redox homeostasis
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
10
Lipid infusion
Oral administration of MitoQ capsules
Beta2-agonist infusion
August Krogh Building
Copenhagen, Denmark
Whole body Insulin sensitivity
Whole body insulin sensitivity is determined by hyperinsulinemic isoglycemic clamp method
Time frame: 5 hours after lipid infusion
Skeletal muscle insulin sensitivity
Insulin-dependent skeletal muscle glucose uptake is determined by hyperinsulinemic isoglycemic clamp method integrated with measurements of femoral artery blood flow and arteriovenous difference of glucose
Time frame: 5 hours after lipid infusion
Mitochondrial respiration
Mitochondrial O2 flux is determined in skeletal muscle biopsies by high-resolution fluorespirometry
Time frame: Baseline
Mitochondrial reactive oxygen species
Mitochondrial H2O2 emission rate is determined in skeletal muscle biopsies by high-resolution fluorespirometry
Time frame: Baseline
Mitochondrial oxidative stress
Peroxiredoxin3 dimer/monomer ratio is determined in skeletal muscle biopsies
Time frame: Before (baseline) as well as 3 and 5 hours after lipid infusion
Muscle redox status
GSH/GSSG ratio is determined in skeletal muscle biopsies
Time frame: Before (baseline) as well as 3 and 5 hours after lipid infusion
Insulin signalling
Phosphorylation status of proteins modulating insulin action is determined in skeletal muscle biopsies
Time frame: Before (baseline) as well as 3 and 5 hours after lipid infusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.